" class="no-js "lang="en-US"> Polyplus - Medtech Alert
Saturday, September 20, 2025
Polyplus | Pharmtech Focus

Polyplus

About Polyplus

Polyplus

Polyplus-transfection SA is a biotechnology company that develops, markets and sells innovative solutions for the in vivo, in vitro and ex vivo delivery of nucleic acids in research, bioproduction and therapeutics. Located close to the University of Strasbourg in Eastern France, Polyplus-transfection has been ISO 9001-certified since 2002 and supplies its proprietary range of reagents for the transfection of genes, oligonucleotides and siRNA through a worldwide distributor network. Polyplus reagents are involved in a growing number of clinical trials worldwide. In addition, Polyplus-transfection holds a broad estate of patents and licenses including original methods for therapeutic siRNA delivery.

Related Story

Exothera Announces Industrial Scale AAV Manufacturing Collaboration With LogicBio Therapeutics and Polyplus

June 15 2022

Exothera SA today announced a collaboration with LogicBio® Therapeutics and Polyplus-transfection® SA. for the development of […]